Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot study. - Aix-Marseille Université Access content directly
Journal Articles Autoimmunity Reviews Year : 2021

Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot study.

Abstract

No abstract available

Dates and versions

hal-03653474 , version 1 (27-04-2022)

Identifiers

Cite

Gilles Kaplanski, Denis Bontemps, Pierre Esnault, Valery Blasco, Julien Carvelli, et al.. Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot study.. Autoimmunity Reviews, 2021, 20 (2), pp.102726. ⟨10.1016/j.autrev.2020.102726⟩. ⟨hal-03653474⟩
5 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More